Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.

Auteurs Botton T, Talevich E, Mishra VK, Zhang T, Shain AH, Berquet C, Gagnon A, Judson RL, Ballotti R, Ribas A, Herlyn M, Rocchi S, Brown KM, Hayward NK, Yeh I, Bastian BC

Cell reports Oct 2019

Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.

Auteurs Botton T, Talevich E, Mishra VK, Zhang T, Shain AH, Berquet C, Gagnon A, Judson RL, Ballotti R, Ribas A, Herlyn M, Rocchi S, Brown KM, Hayward NK, Yeh I, Bastian BC

Cell reports Oct 2019

Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.

Auteurs Botton T, Talevich E, Mishra VK, Zhang T, Shain AH, Berquet C, Gagnon A, Judson RL, Ballotti R, Ribas A, Herlyn M, Rocchi S, Brown KM, Hayward NK, Yeh I, Bastian BC

Cell reports Oct 2019

Nicotinamide as a chemopreventive therapy of skin cancers. Too much of good thing?

Auteurs Ballotti R, Healy E, Bertolotto C

Pigment cell & melanoma research Juil 2019

Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.

Auteurs Tulic MK, Cavazza E, Cheli Y, Jacquel A, Luci C, Cardot-Leccia N, Hadhiri-Bzioueche H, Abbe P, Gesson M, Sormani L, Regazzetti C, Beranger GE, Lereverend C, Pons C, Khemis A, Ballotti R, Bertolotto C, Rocchi S, Passeron T

Nature communications Mai 2019

Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma.

Auteurs Wiedemann GM, Aithal C, Kraechan A, Heise C, Cadilha BL, Zhang J, Duewell P, Ballotti R, Endres S, Bertolotto C, Kobold S

Translational oncology Feb 2019

Lysosomal acid ceramidase ASAH1 controls the transition between invasive and proliferative phenotype in melanoma cells.

Auteurs Leclerc J, Garandeau D, Pandiani C, Gaudel C, Bille K, Nottet N, Garcia V, Colosetti P, Pagnotta S, Bahadoran P, Tondeur G, Mograbi B, Dalle S, Caramel J, Levade T, Ballotti R, Andrieu-Abadie N, Bertolotto C

Oncogene Fév 2019

E2F1 inhibition mediates cell death of metastatic melanoma.

Auteurs Rouaud F, Hamouda-Tekaya N, Cerezo M, Abbe P, Zangari J, Hofman V, Ohanna M, Mograbi B, El-Hachem N, Benfodda Z, Lebeau A, Tulic MK, Hofman P, Bertolotto C, Passeron T, Annicotte JS, Ballotti R, Rocchi S

Cell death & disease Mai 2018

Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.

Auteurs El-Hachem N, Habel N, Naiken T, Bzioueche H, Cheli Y, Beranger GE, Jaune E, Rouaud F, Nottet N, Reinier F, Gaudel C, Colosetti P, Bertolotto C, Ballotti R

Cell death and differentiation Mar 2018

Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.

Auteurs Ohanna M, Cerezo M, Nottet N, Bille K, Didier R, Beranger G, Mograbi B, Rocchi S, Yvan-Charvet L, Ballotti R, Bertolotto C

Genes & development Mar 2018